RNTX

Rein Therapeutics, Inc. Common Stock
RNTX

Overview Fund Activity

20 hedge funds and large institutions have $4.84M invested in Rein Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-7
Holders Change %
-25.93%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$670K
2
BCM
2
Bridgeway Capital Management
Texas
$345K
3
ECM
3
Element Capital Management
New York
$158K
4
PP
4
Paloma Partners
Connecticut
$140K
5
LP
5
LMR Partners
United Kingdom
$71K

Top Sellers

1
BlackRock
1
BlackRock
New York
$88K
2
ECM
2
Endurant Capital Management
California
$0
3
State Street
3
State Street
Massachusetts
$0
4
Northern Trust
4
Northern Trust
Illinois
$0
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
– -$9K -57 Closed
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– -$9K -54 Closed
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
– -$8K -50 Closed
Citigroup
29
Citigroup
New York
– -$8K -49 Closed
Legal & General Group
30
Legal & General Group
United Kingdom
– -$7K -44 Closed
Wells Fargo
31
Wells Fargo
California
– -$7K -42 Closed
AIP
32
Ameritas Investment Partners
Nebraska
– -$3K -22 Closed
1
2